Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Metabonomics and Body Imaging for Metabolic Health Assessment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02372968
Recruitment Status : Completed
First Posted : February 26, 2015
Last Update Posted : February 26, 2015
Sponsor:
Information provided by (Responsible Party):
Nestlé

Brief Summary:
The aim of this pilot study is to develop at Nestlé Research Center a database of metabolic profiles, body composition, food habits and physical activities on a large cohort of human volunteers. Analysis of collected data will serve to measure the variability of the data and to assess the potential of combining metabonomics with imaging techniques (iDXA) to monitor the metabolic and physiologic effects of foods.

Condition or disease Intervention/treatment
Healthy Other: Full body composition and of plasma and urine metabolites

Detailed Description:

The study will be carried out at the metabolic unit of the Nestlé Research Center (Lausanne). A large cohort of subjects will be recruited among Nestlé employees. Body composition will be determined by iDXA (Dual-energy X-ray absorptiometry) and basal metabolism will be measured by metabonomic analysis of urine and plasma samples.

Individual food habits and physical activities will be assessed by questionnaires.

The clinical protocol plans also the measurement of energy expenditure (EE) by indirect calorimetry on a subset of twenty subjects. These EE data will be used to validate iDXA outcomes for resting energy expenditure.

The volunteers can participate a second time to this study in the case they would like to control the evolution of their body composition and metabolism after a period of dietary regime or physical training. In such a case, a minimum period of two months between the visits is required.

After two days of dietary restrictions, the volunteers will come in the morning at the metabolic unit at fasting state, for urine and blood sampling. The metabolism of some foods can bias the metabonomic analyses. Therefore, the consumption of alcoholic beverages, fish meals, liquorice, grapefruit, power drinks and bars, spices, mineral supplements, soft drinks, chocolate, coffee and tea limited to 2 cups per day, are not allowed during two days preceding the visit. In addition, the intake of pain-killers or antiinflammatory drugs is forbidden during the two days before the sampling of urine and blood because their metabolism alters the metabolic profiles of blood and urine.

Antibiotics alter gut microflora, for which the activity represents an important contributor to the urinary metabolic profile. In order to preserve gut microflora-related metabolic information, we recommend a minimum period of one month between the end of any antibiotic therapy and the visit at the metabolic unit.

On the visit day, subjects will come fasting at the metabolic unit, where they will have to:

  • Answer some medical questions during an interview with the doctor in charge of the study
  • Fill in two questionnaires on food habits and physical activities. A dietician of the CHUV will visit you at NRC to ask you for some questions relative to your food habits. This is to validate the new questionnaire you filled in
  • Give a sample of urine
  • Undergo iDXA scan (2 consecutive measures will be run at each of the two visits, in order to assess the intra-individual variability of the results) and measure of the state of hydration by bioimpedance The analysis of plasma samples is recommended to complete the metabonomic analysis. However, the blood sampling will be freely decided by each participant. The protocol plans also to perform measurements of resting energy expenditure by indirect calorimetry on a subset of twenty subjects.

Layout table for study information
Study Type : Observational
Actual Enrollment : 225 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Use of Metabonomics and Body Imaging for Metabolic Health Assessment
Study Start Date : April 2008
Actual Primary Completion Date : April 2009
Actual Study Completion Date : October 2010

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: Full body composition and of plasma and urine metabolites

    Full body composition in lean, fat and bone mass will be assessed from DXA scans.

    Plasma and urine metabolites will be measured using metabolomics



Primary Outcome Measures :
  1. Lean, fat, and bone mass (Measure of full body composition in lean, fat, and bone mass) [ Time Frame: change of body composition after a period of 2 months following baseline ]
    Measure of full body composition in lean, fat, and bone mass

  2. Screening of metabolites in plasma in fasting condition [ Time Frame: Change of plasma metabolites after a period of 2 months post baseline ]
    Measure of plasma metabolites by Nuclear Magnetic Resonance spectroscopy and Mass Spectrometry

  3. Screening of urine metabolites in fasting condition [ Time Frame: Change of urine metabolites after a period of 2 months post baseline ]
    Measure of urine metabolites by Nuclear Magnetic Resonance spectroscopy and Mass Spectrometry

  4. Food habits (Measure of food habits based on Food Frequency Questionnaires) [ Time Frame: Change of food habits after a period of 2 months post baseline ]
    Measure of food habits based on Food Frequency Questionnaires



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Studied population: 100-300 subjects, men and women selected out of Nestlé employees
Criteria

Inclusion Criteria:

All subjects must comply with all the following inclusion criteria:

  • Having respected dietary restrictions 2 days before the visit
  • Having obtained his/her or his/her legal representative's informed consent

Exclusion Criteria:

Subjects representing one or more of the following criteria are excluded from participation in the study:

  • Pregnancy as per precaution principal to avoid risks linked to X-ray exposure
  • Any pathology (infectious or other) having required an antibiotic therapy within

    1 month prior to the beginning of the study

  • Any therapy (contraception apart) within the 2 days before the visit day
  • Subject who cannot be expected to comply with measures
  • Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02372968


Sponsors and Collaborators
Nestlé
Investigators
Layout table for investigator information
Study Director: Serge Rezzi, PhD Nestlé Institute of Health Sciences
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Nestlé
ClinicalTrials.gov Identifier: NCT02372968    
Other Study ID Numbers: 08.03.MET
First Posted: February 26, 2015    Key Record Dates
Last Update Posted: February 26, 2015
Last Verified: February 2015